108 TESTING
CSV exports. This versatility allows teams to tailor their reporting for internal reviews, regulatory submissions, or marketing materials. One of the most valuable aspects of these
systems is their ability to standardize data across global testing sites. Whether a study is conducted in North America, Europe, or Asia, the same measurement protocols and software outputs ensure consistency. This harmonisation is essential for multinational brands seeking to launch products in multiple markets with unified claims. Visual documentation also enhances
credibility. When measurement images are saved alongside data, they provide a clear record of the test site and conditions. This is useful in studies where researchers must demonstrate that the same skin area was evaluated over time. Such documentation strengthens the reliability of the findings and supports repeatability. Additionally, the ability to export data in
universally compatible formats streamlines collaboration. Formulators, clinical researchers, and marketing teams can all access the same dataset, interpret results from their unique perspectives, and align on messaging. This integrated workflow accelerates decision-making and reduces the risk of miscommunication. In marketing, these data points can be
translated into consumer-facing claims such as ‘clinically proven to reduce redness by 25% in four weeks’, backed by visual graphs and before- and-after images. This bridges the gap between science and storytelling.
Microbiome-friendly testing As microbiome research advances, some testing protocols now include genomic sequencing or microbial diversity analysis. While these methods are outside the scope of colorimetric evaluation, they can be complemented by minimally invasive skin measurement tools to provide a more complete picture of product impact. This integrated approach supports the development of formulations that are both effective and microbiome-safe. As the skin care industry embraces the
importance of the skin microbiome, testing methodologies must evolve to accommodate this delicate ecosystem. The microbiome—a diverse community of microorganisms living on the skin— plays a vital role in maintaining barrier function, regulating inflammation, and supporting overall skin health. Disrupting it during product testing can lead to misleading results or unintended side effects.
This has led to a growing demand for non-
disruptive, microbiome-friendly evaluation techniques. Traditional methods that involve swabbing, scraping, or applying reactive agents may interfere with the skin’s natural balance. In contrast, modern skin measurement systems offer a gentler alternative. By using optical sensors and minimally invasive approaches, these tools preserve the integrity of the skin surface while still capturing high-resolution data. Such technologies are particularly valuable in studies involving sensitive skin types or
formulations marketed as microbiome-safe. They allow researchers to monitor changes in pigmentation, redness, and tone without compromising the skin’s microbial environment. This ensures that observed improvements are due to the product itself—not the testing process. Additionally, the ergonomic design and
intuitive operation of these devices reduce the need for prolonged contact or repeated handling. This minimizes the risk of irritation and supports ethical testing practices, especially in longitudinal studies where skin is evaluated over extended periods. By aligning with microbiome-conscious
principles, these skin evaluation systems help cosmetic developers meet the rising consumer demand for gentle, science-backed skin care. They offer a path forward for testing that is both effective and respectful of the skin’s natural biology.
Conclusion As the industry moves toward greater accountability, the role of objective skin evaluation will only grow. These technologies not only enhance the credibility of cosmetic claims but also foster innovation by providing researchers with actionable insights. By embracing data- driven methodologies, brands can differentiate themselves in a crowded marketplace and build lasting trust with consumers who value transparency and results. As the personal care industry continues to
evolve, the integration of objective skin evaluation technologies has become not just beneficial—but essential. In an era where consumers demand transparency and regulators enforce scientific rigor, cosmetic brands must substantiate their claims with data that is both credible and reproducible. Tools like Konica Minolta’s CM-17d spectrophotometer and CM-SA2 skin analysis software are redefining how efficacy is measured, communicated, and trusted. By quantifying critical skin parameters such as melanin concentration, haemoglobin levels, and ITA°, these technologies enable researchers to track subtle yet meaningful changes in skin tone, brightness, and redness with precision. Their ability to support microbiome-friendly testing ensures that skin integrity is preserved throughout the evaluation process—an increasingly important factor in today’s formulation landscape. Beyond measurement, these tools foster
global collaboration. With standardized protocols, graphical outputs, and CSV exports, teams across continents can align on testing methodologies and share results seamlessly. This harmonization accelerates product development, strengthens regulatory submissions, and enhances consumer confidence. Ultimately, objective skin analysis is no longer
a differentiator—it is the foundation of modern cosmetic science. With technologies like CM-17d and CM-SA2, brands can move from innovation to validation with clarity and confidence, ensuring that every product promise is backed by measurable evidence and every launch is built on trust.
PERSONAL CARE MAGAZINE October 2026
PCM
www.personalcaremagazine.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132
